InterCure Ltd. (NASDAQ:INCR) Sees Large Growth in Short Interest

InterCure Ltd. (NASDAQ:INCR) was the target of a large growth in short interest in July. As of July 31st, there was short interest totaling 30,600 shares, agrowthof52.2% from the July 15th total of 20,100 shares. Based on an average trading volume of 25,800 shares, the short-interest ratio is currently 1.2 days. Approximately0.1% of the company’s stock are short sold. Approximately0.1% of the company’s stock are short sold. Based on an average trading volume of 25,800 shares, the short-interest ratio is currently 1.2 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in InterCure stock. Moore Capital Management LP acquired a new position in InterCure Ltd. (NASDAQ:INCR) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 97,273 shares of the company’s stock, valued at approximately $156,000. Moore Capital Management LP owned approximately 0.21% of InterCure as of its most recent filing with the Securities and Exchange Commission (SEC). 8.34% of the stock is currently owned by institutional investors and hedge funds.

InterCure Stock Performance

Shares of NASDAQ INCR opened at $1.61 on Tuesday. The stock’s 50-day simple moving average is $1.52 and its 200-day simple moving average is $1.52. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.73 and a quick ratio of 1.18. InterCure has a fifty-two week low of $1.17 and a fifty-two week high of $2.30.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.